Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy

Nivolumab improves overall survival (OS) in patients with advanced gastric cancer (AGC) refractory to at least two previous chemotherapy regimens. We investigated whether changes in body weight and nutrition from first-line chemotherapy to nivolumab affected its efficacy. The correlation between wei...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikoma, Tatsuki, Matsumoto, Toshihiko, Kurioka, Yusuke, Takatani, Masahiro, Nagai, Hiroki, Matsumoto, Yusuke, Satake, Hironaga, Yasui, Hisateru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605511/
https://www.ncbi.nlm.nih.gov/pubmed/36294421
http://dx.doi.org/10.3390/jcm11206100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605511/
https://www.ncbi.nlm.nih.gov/pubmed/36294421
http://dx.doi.org/10.3390/jcm11206100

Ejemplares similares